Pyrazine derivatives useful as inhibitors of ATR kinase

Abstract The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; me thods of treating of various diseases, disorders, and conditions using the co...

Full description

Saved in:
Bibliographic Details
Main Authors DURRANT, Steven, REAPER, Philip Michael, MACCORMICK, Somhairle, PINDER, Joanne, KAY, David, VIRANI, Anisa Nizarali, YOUNG, Stephen, KNEGTEL, Ronald, O'DONNELL, Michael, MORTIMORE, Michael, CHARRIER, Jean-Damien, RUTHERFORD, Alistair
Format Patent
LanguageEnglish
Published 18.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; me thods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermedia tes fo r the prepara tion of the com pound s of this inve ntion; an d method s of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the com parative evaluation of n ew kin ase inhibitors. The compo un ds of this invention have formula (I):whereir the variables are as defined herein
Bibliography:Application Number: AU20180201363